Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2005 3
2006 2
2009 2
2011 3
2012 1
2014 2
2015 2
2016 4
2017 4
2018 1
2019 3
2020 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Left ventricular noncompaction 8"
Page 1
Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview.
Bhatia NL, Tajik AJ, Wilansky S, Steidley DE, Mookadam F. Bhatia NL, et al. J Card Fail. 2011 Sep;17(9):771-8. doi: 10.1016/j.cardfail.2011.05.002. J Card Fail. 2011. PMID: 21872148 Review.
BACKGROUND: Owing to inconsistent diagnostic criteria and small heterogeneous cohorts, little is known about the long-term outcomes of adult left ventricular noncompaction (LVNC), a rare cardiomyopathy with potentially serious outcomes. ...The annualized even …
BACKGROUND: Owing to inconsistent diagnostic criteria and small heterogeneous cohorts, little is known about the long-term outcomes of adult …
Left Ventricular Noncompaction and Cardiogenic Shock.
Kazmirczak F, Martin CM, Shenoy C. Kazmirczak F, et al. Circulation. 2020 Feb 25;141(8):696-701. doi: 10.1161/CIRCULATIONAHA.119.043716. Epub 2020 Feb 24. Circulation. 2020. PMID: 32091931 Free PMC article. No abstract available.
Ventricular arrhythmias associated with left ventricular noncompaction: Electrophysiologic characteristics, mapping, and ablation.
Muser D, Liang JJ, Witschey WR, Pathak RK, Castro S, Magnani S, Zado ES, Garcia FC, Desjardins B, Callans DJ, Frankel DS, Marchlinski FE, Santangeli P. Muser D, et al. Heart Rhythm. 2017 Feb;14(2):166-175. doi: 10.1016/j.hrthm.2016.11.014. Epub 2016 Nov 24. Heart Rhythm. 2017. PMID: 27890738
BACKGROUND: Left ventricular noncompaction (LVNC) is a primary cardiomyopathy that can present with recurrent ventricular arrhythmias (VAs). ...Ablation sites were identified using a combination of entrainment, activation, late/fractionated potential a …
BACKGROUND: Left ventricular noncompaction (LVNC) is a primary cardiomyopathy that can present with recurrent ventri
Frequency of stroke and embolism in left ventricular hypertrabeculation/noncompaction.
Stöllberger C, Blazek G, Dobias C, Hanafin A, Wegner C, Finsterer J. Stöllberger C, et al. Am J Cardiol. 2011 Oct 1;108(7):1021-3. doi: 10.1016/j.amjcard.2011.05.039. Epub 2011 Jul 23. Am J Cardiol. 2011. PMID: 21784395
Left ventricular hypertrabeculation/noncompaction (LVHT/NC) is associated with stroke or embolism (S/E). ...In conclusion, S/E in patients with LVHT/NC is not always cardioembolic but may also have an atherosclerotic cause. In the absence of AF or left
Left ventricular hypertrabeculation/noncompaction (LVHT/NC) is associated with stroke or embolism (S/E). ...In conclusi
Medical Therapy Leads to Favorable Remodeling in Left Ventricular Non-compaction Cardiomyopathy: Dilated Phenotype.
Parent JJ, Towbin JA, Jefferies JL. Parent JJ, et al. Pediatr Cardiol. 2016 Apr;37(4):674-7. doi: 10.1007/s00246-015-1330-2. Epub 2016 Jan 2. Pediatr Cardiol. 2016. PMID: 26724283
Left ventricular non-compaction cardiomyopathy (LVNC) is a distinct and heterogeneous entity that can lead to progressive cardiac dysfunction and heart failure. LVNC with dilation and/or dysfunction is associated with a greater mortality risk. We hypothesized
Left ventricular non-compaction cardiomyopathy (LVNC) is a distinct and heterogeneous entity that can lead to progressive card
Clinical outcomes in patients with isolated left ventricular noncompaction and heart failure.
Peters F, Khandheria BK, Botha F, Libhaber E, Matioda H, Dos Santos C, Govender S, Meel R, Essop MR. Peters F, et al. J Card Fail. 2014 Oct;20(10):709-715. doi: 10.1016/j.cardfail.2014.07.007. Epub 2014 Jul 29. J Card Fail. 2014. PMID: 25079299
BACKGROUND: We prospectively evaluated long-term clinical outcomes of patients diagnosed with isolated left ventricular noncompaction (ILVNC) and heart failure from a sub-Saharan African population. ...Recurrent heart failure developed in …
BACKGROUND: We prospectively evaluated long-term clinical outcomes of patients diagnosed with isolated left ventricular
Implantable Cardioverter Defibrillators in Infants and Toddlers: Indications, Placement, Programming, and Outcomes.
Zahedivash A, Hanisch D, Dubin AM, Trela A, Chubb H, Motonaga KS, Goodyer WR, Maeda K, Reinhartz O, Ma M, Martin E, Ceresnak SR. Zahedivash A, et al. Circ Arrhythm Electrophysiol. 2022 Feb;15(2):e010557. doi: 10.1161/CIRCEP.121.010557. Epub 2022 Jan 28. Circ Arrhythm Electrophysiol. 2022. PMID: 35089800
ICDs were placed for secondary prevention in 12 patients (80%). Diagnoses included 8 long-QT syndromes (53%), 4 idiopathic ventricular tachycardias/ventricular fibrillations (VFs; 27%), 1 recurrent ventricular tachycardia with cardiomyopathy (7%), 1 VF …
ICDs were placed for secondary prevention in 12 patients (80%). Diagnoses included 8 long-QT syndromes (53%), 4 idiopathic ventric
Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in Turkish population (LVH-TR).
Kis M, Dogan Y, Yildirim A, Güzel T, Bekar L, Akhan O, Dogdus M, Harbalıoğlu H, Karabulut D, Soydan E, Zoghi M, Ergene O; LVH-TR Study Collaborates. Kis M, et al. Acta Cardiol. 2022 Nov;77(9):836-845. doi: 10.1080/00015385.2022.2119670. Epub 2022 Oct 12. Acta Cardiol. 2022. PMID: 36222672
BACKGROUND: Left ventricular hypertrophy (LVH) is potentially modifiable cardiovascular risk factor often overlooked in clinical practice. For this reason, we planned to LVH-TR (Left Ventricular Hypertrophy in Turkish Population) trial to …
BACKGROUND: Left ventricular hypertrophy (LVH) is potentially modifiable cardiovascular risk factor often overlooked in cli
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction.
Grigoratos C, Barison A, Ivanov A, Andreini D, Amzulescu MS, Mazurkiewicz L, De Luca A, Grzybowski J, Masci PG, Marczak M, Heitner JF, Schwitter J, Gerber BL, Emdin M, Aquaro GD. Grigoratos C, et al. JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2141-2151. doi: 10.1016/j.jcmg.2018.12.029. Epub 2019 Mar 13. JACC Cardiovasc Imaging. 2019. PMID: 30878415 Free article.
OBJECTIVES: The objective of this meta-analysis was to assess the predictive value of late gadolinium enhancement (LGE) and global systolic impairment for future major adverse cardiovascular events in left ventricular noncompaction (LVNC). BACKGROUND: The pro …
OBJECTIVES: The objective of this meta-analysis was to assess the predictive value of late gadolinium enhancement (LGE) and global systolic …
Cellular cardiac regenerative therapy in which patients?
Chachques JC. Chachques JC. Expert Rev Cardiovasc Ther. 2009 Aug;7(8):911-9. doi: 10.1586/erc.09.84. Expert Rev Cardiovasc Ther. 2009. PMID: 19673669 Review.
Current indications for stem cell therapy concern patients who have had a left- or right-ventricular infarction or idiopathic dilated cardiomyopathies. Other indications and potential applications include patients with diabetic cardiomyopathy, Chagas heart di …
Current indications for stem cell therapy concern patients who have had a left- or right-ventricular infarction or idiopathic …
32 results